Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05666856 · ClinicalTrials.gov registry record · NA
Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones
A NA study of Substance-Related Disorders and Family Health, sponsored by We The Village.
- Active
- Registry status
- NA
- Development phase
- 212
- Enrollment target
- 1
- Study location
NCT05666856: Active NA study of Substance-Related Disorders and Family Health, sponsored by We The Village.
NCT05666856 is a NA study of Substance-Related Disorders and Family Health that is active but no longer recruiting, run by We The Village. The registered enrollment target is 212 participants, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05666856, a NA study of Substance-Related Disorders and Family Health, is active but no longer recruiting, sponsored by We The Village.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
- 1
- Study location
Study Summary
The United States is in the midst of an opioid crisis. Over-prescription of opioid analgesic pain relievers contributed to a rapid escalation of use and misuse of these substances across the country. In 2016, more than 2.6 million Americans were diagnosed with opioid use disorder (OUD) and more than 42,000 have died of overdose involving opioids. This death rate is more than any year on record and has quadrupled since 1999 (1,2). Leveraging the potential of available data bases and health IT technologies may help to combat opioid crisis by targeting various aspects of the problem ranging from the prevention of opioid misuse to OUD treatment. NIH through NIDA solicits the research and development of data-driven solutions and services that focus on issues related to opioid use prevention, opioid use, opioid overdose prevention or OUD treatment. In this project, We The Village, Inc. will address a need to prepare Concerned Significant Others (CSOs) to best use their influence over the trajectory of a loved one's OUD. CSOs are motivated to help, make majority of treatment decisions and payments and have influence over treatment entry and thus, impact the trajectory of an OUD. The goal of the project is to establish the technical efficacy and commercial viability of CRAFT-A at scale by conducting the fully powered randomized controlled trial (RCT) comparing two online interventions: CRAFT-A (hereinafter referred to as CRAFT or digital CRAFT) and PEER support (the original comparison group). Based on Phase I findings, the team anticipates the CRAFT condition will achieve better outcomes than the PEER condition in a) treatment entry and retention, b) Concerned Significant Others' (CSO) health and wellbeing, c) CSO-IP relationship, and d) CRAFT knowledge.
Conditions Studied
Interventions
- BEHAVIORAL Community Reinforcement And Family Training
- BEHAVIORAL We The Village Peer Community Forum
Study Locations (1)
New York
- We The Village, Inc. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2022-11-29 |
| Est. Completion | 2024-09-22 |
| Phase | NA |
What the registry record for NCT05666856 still lists
NCT05666856 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Community Reinforcement And Family Training is the first listed.
NCT05666856 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05666856 about?
NCT05666856 is a clinical study titled "Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones". The United States is in the midst of an opioid crisis. Over-prescription of opioid analgesic pain relievers contributed to a rapid escalation of use and misuse of these substances across the country. In 2016, more than 2.6 million Americans were diagnosed with opioid use disorder (OUD) and more than...
What is the current status of trial NCT05666856?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 212 participants. The study started on 2022-11-29. Estimated completion is 2024-09-22.
What conditions does trial NCT05666856 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Family Health, Community Reinforcement And Family Training.
What interventions are being tested in trial NCT05666856?
The interventions under investigation include: Community Reinforcement And Family Training (BEHAVIORAL), We The Village Peer Community Forum (BEHAVIORAL).
Who is sponsoring clinical trial NCT05666856?
This trial is sponsored by We The Village, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05666856 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05666856's enrollment target sits among peer trials
212 20th of 58 higher than 39 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI